Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Glioblastoma D005909 27 associated lipids
Fabry Disease D000795 4 associated lipids
Influenza, Human D007251 11 associated lipids
Retinal Detachment D012163 10 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Atherosclerosis D050197 85 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Insulin Resistance D007333 99 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Radi ZA and Vogel MW Gastric parietal cell atrophy and depletion after administration of a sphingosine-1-phosphate 1 inhibitor. 2014 Toxicol Pathol pmid:24178572
Che W et al. Corticosteroids inhibit sphingosine 1-phosphate-induced interleukin-6 secretion from human airway smooth muscle via mitogen-activated protein kinase phosphatase 1-mediated repression of mitogen and stress-activated protein kinase 1. 2014 Am. J. Respir. Cell Mol. Biol. pmid:24032470
Chang N et al. Sphingosine 1-phosphate receptors negatively regulate collagen type I/III expression in human bone marrow-derived mesenchymal stem cell. 2014 J. Cell. Biochem. pmid:24038457
Völzke A et al. Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells. 2014 Biochim. Biophys. Acta pmid:24064301
Pyne NJ et al. The role of sphingosine 1-phosphate in inflammation and cancer. 2014 Adv Biol Regul pmid:24070975
Nguyen-Tran DH et al. Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy. 2014 Dis Model Mech pmid:24077965
Tanaka K et al. Anti-interleukin-6 receptor antibody prevents systemic bone mass loss via reducing the number of osteoclast precursors in bone marrow in a collagen-induced arthritis model. 2014 Clin. Exp. Immunol. pmid:24028747
Kihara A Sphingosine 1-phosphate is a key metabolite linking sphingolipids to glycerophospholipids. 2014 Biochim. Biophys. Acta pmid:23994042
Moxon JV et al. Comparison of the serum lipidome in patients with abdominal aortic aneurysm and peripheral artery disease. 2014 Circ Cardiovasc Genet pmid:24448739
Gorlino CV et al. Neutrophils exhibit differential requirements for homing molecules in their lymphatic and blood trafficking into draining lymph nodes. 2014 J. Immunol. pmid:25015824
Anderson G and Maes M Reconceptualizing adult neurogenesis: role for sphingosine-1-phosphate and fibroblast growth factor-1 in co-ordinating astrocyte-neuronal precursor interactions. 2014 CNS Neurol Disord Drug Targets pmid:24040808
Waeber C and Walther T Sphingosine-1-phosphate as a potential target for the treatment of myocardial infarction. 2014 Circ. J. pmid:24632793
Brünnert D et al. Lysophosphatidic acid and sphingosine 1-phosphate metabolic pathways and their receptors are differentially regulated during decidualization of human endometrial stromal cells. 2014 Mol. Hum. Reprod. pmid:24994816
Nagamatsu T et al. Emerging roles for lysophospholipid mediators in pregnancy. 2014 Am. J. Reprod. Immunol. pmid:24689547
Shimizu Y et al. Potentials of the circulating pruritogenic mediator lysophosphatidic acid in development of allergic skin inflammation in mice: role of blood cell-associated lysophospholipase D activity of autotaxin. 2014 Am. J. Pathol. pmid:24641902
Snider AJ et al. Distinct roles for hematopoietic and extra-hematopoietic sphingosine kinase-1 in inflammatory bowel disease. 2014 PLoS ONE pmid:25460165
Huang K et al. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose. 2014 Cell. Signal. pmid:24342046
Slattum G et al. Autophagy in oncogenic K-Ras promotes basal extrusion of epithelial cells by degrading S1P. 2014 Curr. Biol. pmid:24361067
Miller DS Sphingolipid signaling reduces basal P-glycoprotein activity in renal proximal tubule. 2014 J. Pharmacol. Exp. Ther. pmid:24385389
Dai L et al. Sphingosine 1-phosphate: a potential molecular target for ovarian cancer therapy? 2014 Cancer Invest. pmid:24499107
Ito K et al. Integrin α9 on lymphatic endothelial cells regulates lymphocyte egress. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24516133
Nakajima C et al. The lipoprotein receptor LRP1 modulates sphingosine-1-phosphate signaling and is essential for vascular development. 2014 Development pmid:25377550
Takeshita E et al. Diacylglycerol kinase γ is a novel anionic phospholipid binding protein with a selective binding preference. 2014 Biochem. Biophys. Res. Commun. pmid:24486543
Barnes J and Dweik RA Is pulmonary hypertension a metabolic disease? 2014 Am. J. Respir. Crit. Care Med. pmid:25360726
Kamiya T et al. Role of Ca2+ -dependent and Ca2+ -sensitive mechanisms in sphingosine 1-phosphate-induced constriction of isolated porcine retinal arterioles in vitro. 2014 Exp. Eye Res. pmid:24486793
Plano D et al. Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors. 2014 J. Med. Chem. pmid:24471412
Nakamura H and Murayama T Role of sphingolipids in arachidonic acid metabolism. 2014 J. Pharmacol. Sci. pmid:24599139
Guo S et al. Higher level of plasma bioactive molecule sphingosine 1-phosphate in women is associated with estrogen. 2014 Biochim. Biophys. Acta pmid:24603322
Kempf A et al. The sphingolipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity. 2014 PLoS Biol. pmid:24453941
Sutter I et al. Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate. 2014 J. Lipid Res. pmid:24950692
Xiong Y et al. Erythrocyte-derived sphingosine 1-phosphate is essential for vascular development. 2014 J. Clin. Invest. pmid:25250575
Tan SJ et al. Targeted anti-apoptosis activity for ovarian protection against chemotherapy-induced ovarian gonadotoxicity. 2014 Reprod. Biomed. Online pmid:25246113
Goñi FM et al. Biophysical properties of sphingosine, ceramides and other simple sphingolipids. 2014 Biochem. Soc. Trans. pmid:25233422
Yagoub D et al. Sphingosine kinase 1 isoform-specific interactions in breast cancer. 2014 Mol. Endocrinol. pmid:25216046
Yang W et al. Sphingosine-1-phosphate promotes extravillous trophoblast cell invasion by activating MEK/ERK/MMP-2 signaling pathways via S1P/S1PR1 axis activation. 2014 PLoS ONE pmid:25188412
Martin R and Sospedra M Sphingosine-1 phosphate and central nervous system. 2014 Curr. Top. Microbiol. Immunol. pmid:24728597
Chen J et al. The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension. 2014 Am. J. Respir. Crit. Care Med. pmid:25180446
Kong Y et al. Sphingosine-1-phosphate/S1P receptors signaling modulates cell migration in human bone marrow-derived mesenchymal stem cells. 2014 Mediators Inflamm. pmid:25147438
Shayegi N et al. CXCR4 blockade and sphingosine-1-phosphate activation facilitate engraftment of haematopoietic stem and progenitor cells in a non-myeloablative transplant model. 2014 Br. J. Haematol. pmid:24180707
Nagahashi M et al. Sphingosine-1-phosphate transporters as targets for cancer therapy. 2014 Biomed Res Int pmid:25133174
Kim ES et al. Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression. 2014 Oncogene pmid:23955082
St John AL et al. S1P-Dependent trafficking of intracellular yersinia pestis through lymph nodes establishes Buboes and systemic infection. 2014 Immunity pmid:25238098
Davis KM and Isberg RR Plague's partners in crime. 2014 Immunity pmid:25238090
Fuerst E et al. Sphingosine-1-phosphate induces pro-remodelling response in airway smooth muscle cells. 2014 Allergy pmid:25041788
Murakami M et al. Controlled release of sphingosine-1-phosphate agonist with gelatin hydrogels for macrophage recruitment. 2014 Acta Biomater pmid:25038462
Park SJ et al. Sphingosine 1-phosphate induced anti-atherogenic and atheroprotective M2 macrophage polarization through IL-4. 2014 Cell. Signal. pmid:25035231
Kim EY et al. Role of sphingosine kinase 1 and sphingosine-1-phosphate in CD40 signaling and IgE class switching. 2014 FASEB J. pmid:25002116
Schwalm S et al. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases. 2014 Basic Clin. Pharmacol. Toxicol. pmid:23789924
Hao J et al. The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation. 2014 Arthritis Res. Ther. pmid:25000985
Tsai YC et al. Antiapoptotic agent sphingosine-1-phosphate protects vitrified murine ovarian grafts. 2014 Reprod Sci pmid:23793475
Rauch BH Sphingosine 1-phosphate as a link between blood coagulation and inflammation. 2014 Cell. Physiol. Biochem. pmid:24977491
Sattler K et al. HDL-bound sphingosine 1-phosphate (S1P) predicts the severity of coronary artery atherosclerosis. 2014 Cell. Physiol. Biochem. pmid:24977490
Thuy AV et al. Sphingosine 1-phosphate in blood: function, metabolism, and fate. 2014 Cell. Physiol. Biochem. pmid:24977489
van Echten-Deckert G et al. Sphingosine-1-phosphate: boon and bane for the brain. 2014 Cell. Physiol. Biochem. pmid:24977488
Fayyaz S et al. Divergent role of sphingosine 1-phosphate on insulin resistance. 2014 Cell. Physiol. Biochem. pmid:24977487
Simmons S and Ishii M Sphingosine-1-phosphate: a master regulator of lymphocyte egress and immunity. 2014 Arch. Immunol. Ther. Exp. (Warsz.) pmid:24276789
Poitevin S et al. Sphingosine kinase 1 expressed by endothelial colony-forming cells has a critical role in their revascularization activity. 2014 Cardiovasc. Res. pmid:24743591
Mahajan-Thakur S et al. Sphingosine-1-phosphate induces thrombin receptor PAR-4 expression to enhance cell migration and COX-2 formation in human monocytes. 2014 J. Leukoc. Biol. pmid:24990321
O'Sullivan MJ et al. Sphingosine 1-phosphate (S1P) induced interleukin-8 (IL-8) release is mediated by S1P receptor 2 and nuclear factor κB in BEAS-2B cells. 2014 PLoS ONE pmid:24743449
Jesko H et al. Sphingosine kinases modulate the secretion of amyloid β precursor protein from SH-SY5Y neuroblastoma cells: the role of α-synuclein. 2014 Folia Neuropathol pmid:24729344
Zhu Y et al. Vitamin D therapy in experimental allergic encephalomyelitis could be limited by opposing effects of sphingosine 1-phosphate and gelsolin dysregulation. 2014 Mol. Neurobiol. pmid:24722820
Kondo S et al. Memo has a novel role in S1P signaling and is [corrected] crucial for vascular development. 2014 PLoS ONE pmid:24714781
Korbelik M et al. Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposure. 2014 Int. Immunopharmacol. pmid:24713544
Gatfield J et al. Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling. 2014 Cell. Signal. pmid:24704119
Shin KO et al. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells. 2014 Arch. Pharm. Res. pmid:24687256
Yu H et al. Sphingosine kinase 1 improves cutaneous wound healing in diabetic rats. 2014 Injury pmid:24685054
Sykes DA et al. Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization. 2014 Br. J. Pharmacol. pmid:24641481
Blaho VA and Hla T An update on the biology of sphingosine 1-phosphate receptors. 2014 J. Lipid Res. pmid:24459205
Shen Z et al. Sphingosine 1-phosphate (S1P) promotes mitochondrial biogenesis in Hep G2 cells by activating Peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α). 2014 Cell Stress Chaperones pmid:24293320
Chen JJ et al. Non-genomic rapid responses via progesterone in human peripheral T cells are not indirectly mimicked by sphingosine 1-phosphate. 2014 Steroids pmid:24269742
Whisler JA et al. Control of perfusable microvascular network morphology using a multiculture microfluidic system. 2014 Tissue Eng Part C Methods pmid:24151838
Mendes-Braz M et al. The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion. 2014 Liver Int. pmid:24107124
Baranowski M et al. Ultramarathon run markedly reduces plasma sphingosine-1-phosphate concentration. 2014 Int J Sport Nutr Exerc Metab pmid:24092763
Abu El-Asrar AM et al. Expression of bioactive lysophospholipids and processing enzymes in the vitreous from patients with proliferative diabetic retinopathy. 2014 Lipids Health Dis pmid:25496321
Jensen T et al. The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor function. 2014 Bioorg. Med. Chem. Lett. pmid:25442311
Ye C et al. Identification of a novel small-molecule agonist for human G protein-coupled receptor 3. 2014 J. Pharmacol. Exp. Ther. pmid:24633425
Pyszko J and Strosznajder JB Sphingosine kinase 1 and sphingosine-1-phosphate in oxidative stress evoked by 1-methyl-4-phenylpyridinium (MPP+) in human dopaminergic neuronal cells. 2014 Mol. Neurobiol. pmid:24399507
Fincher J et al. G-protein-coupled receptor cell signaling pathways mediating embryonic chick retinal growth cone collapse induced by lysophosphatidic acid and sphingosine-1-phosphate. 2014 Dev. Neurosci. pmid:25138637
Neuber C et al. Method to simultaneously determine the sphingosine 1-phosphate breakdown product (2E)-hexadecenal and its fatty acid derivatives using isotope-dilution HPLC-electrospray ionization-quadrupole/time-of-flight mass spectrometry. 2014 Anal. Chem. pmid:25137547
Rao PV Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma. 2014 Mar-Apr J Ocul Pharmacol Ther pmid:24283588
Pulli I et al. A novel chimeric aequorin fused with caveolin-1 reveals a sphingosine kinase 1-regulated Ca²⁺ microdomain in the caveolar compartment. 2015 Biochim. Biophys. Acta pmid:25892494
Zankov DP and Ogita H Actin-tethered junctional complexes in angiogenesis and lymphangiogenesis in association with vascular endothelial growth factor. 2015 Biomed Res Int pmid:25883953
Williams PA et al. Hypoxia augments outgrowth endothelial cell (OEC) sprouting and directed migration in response to sphingosine-1-phosphate (S1P). 2015 PLoS ONE pmid:25875493
Schröder M et al. Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application. 2015 Biol. Chem. pmid:25720062
Koch A et al. Downregulation of sphingosine 1-phosphate (S1P) receptor 1 by dexamethasone inhibits S1P-induced mesangial cell migration. 2015 Biol. Chem. pmid:25719311
Park ES et al. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction. 2015 J. Biol. Chem. pmid:25716317
Rhee SH et al. Pelvic organ prolapse is associated with alteration of sphingosine-1-phosphate/Rho-kinase signalling pathway in human vaginal wall. 2015 J Obstet Gynaecol pmid:25692679
Roviezzo F et al. S1P-induced airway smooth muscle hyperresponsiveness and lung inflammation in vivo: molecular and cellular mechanisms. 2015 Br. J. Pharmacol. pmid:25439580
Carroll B et al. Sphingolipids in the DNA damage response. 2015 Adv Biol Regul pmid:25434743
Xiu L et al. Intracellular sphingosine 1-phosphate contributes to collagen expression of hepatic myofibroblasts in human liver fibrosis independent of its receptors. 2015 Am. J. Pathol. pmid:25432063
Moon MH et al. Activation of S1P2 receptor, a possible mechanism of inhibition of adipogenic differentiation by sphingosine 1‑phosphate. 2015 Mol Med Rep pmid:25351259
Iwabuchi K et al. Role of Ceramide from Glycosphingolipids and Its Metabolites in Immunological and Inflammatory Responses in Humans. 2015 Mediators Inflamm. pmid:26609196
Jeong JK et al. Modulation of the expression of sphingosine 1-phosphate 2 receptors regulates the differentiation of pre-adipocytes. 2015 Mol Med Rep pmid:26459774
Li C et al. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3. 2015 J Neuroinflammation pmid:25880547
Adamiak M et al. Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow. 2015 Oncotarget pmid:26299919
Mori H et al. Smad3 deficiency leads to mandibular condyle degradation via the sphingosine 1-phosphate (S1P)/S1P3 signaling axis. 2015 Am. J. Pathol. pmid:26272361
Chen MH et al. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma. 2015 Oncotarget pmid:26090720
Panneer Selvam S et al. Binding of the sphingolipid S1P to hTERT stabilizes telomerase at the nuclear periphery by allosterically mimicking protein phosphorylation. 2015 Sci Signal pmid:26082434
Malik FA et al. Sphingosine-1-Phosphate Is a Novel Regulator of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity. 2015 PLoS ONE pmid:26079370
Mooren OL et al. Role of N-WASP in Endothelial Monolayer Formation and Integrity. 2015 J. Biol. Chem. pmid:26070569